SYNTHESIS PURIFICATION DRUG LIKE

Brand Owner (click to sort) Address Description
TRANSTECH PHARMA TransTech Pharma, Inc. 4170 Mendenhall Oaks Parkway Suite 110 High Point NC 27265 synthesis and purification of drug-like compounds for others for the purpose of discovering authentic clinical drug candidates, and consultation services related thereto;pharmaceutical drug development services and consultation services related thereto; pharmaceutical research services for the discovery of authentic clinical drug candidates, namely, design, analysis, testing, optimization, and profiling of drug-like compounds; pharmaceutical drug chemical analysis services and assay services for others; chemical laboratory services; and pharmaceutical research services for others in the nature of database development services and design of software development tools, search engines, data mining software, and computer models;
TRANSTECH PHARMA TransTech Pharma, Inc. 4170 Mendenhall Oaks Parkway Suite 110 High Point NC 27265 Synthesis and purification of drug-like compounds for others for the purpose of discovering authentic clinical drug candidates, and consultation services related thereto;TRANS TECH PHARMA;Color is not claimed as a feature of the mark.;Pharmaceutical drug development services and consultation services related thereto; pharmaceutical research services for the discovery of authentic clinical drug candidates, namely, design, analysis, testing, optimization, and profiling of drug-like compounds; pharmaceutical drug chemical analysis services and assay services for others; chemical laboratory services; and pharmaceutical research services for others in the nature of database development services and design of software development tools, search engines, data mining software, and computer models;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. Disclosed is the characterization and purification of DNA encoding polypeptides useful for the stimulation of glial cell mitogenesis. Methods for the synthesis, purification and testing of both known and novel polypeptides for their use as both therapeutic and diagnostic aids in the treatment of diseases involving glial cells are also provided. Methods are also provided for the use of these polypeptides in the prevention or treatment of multiple sclerosis.